NAD Injections Explained.

The terms are often used interchangeably but describe different delivery routes. A NAD injection refers to subcutaneous (SubQ) or intramuscular (IM) administration using a syringe — doses are lower (25–200 mg) and absorption is gradual. NAD+ IV therapy delivers a larger dose (typically 500 mg) directly into a vein over 2–4 hours, achieving 100% bioavailability and immediate systemic effect. TrufaMED uses IV as the primary therapeutic route, with SubQ available as physician-prescribed maintenance.

SubQ NAD+ injection can be self-administered at home — but only under physician supervision, with proper training, using pharmaceutical-grade compounded vials, and with a valid prescription. Online vendors selling NAD+ vials without physician involvement should be avoided. Purity, concentration, and sterility cannot be verified without clinical oversight. At TrufaMED, we prescribe SubQ maintenance kits and provide training to qualified patients following their initial IV session and consultation.

Frequency depends on your goals, current NAD+ status, and clinical history. A common loading protocol for new patients involves 2–4 IV sessions over the first month, then monthly maintenance. Patients using SubQ between IV sessions typically inject daily to 3 times per week at lower doses. There is no single correct frequency — this is determined during your physician consultation based on your individual needs and response to initial sessions.

At TrufaMED, NAD+ IV therapy is $999 per session at our Surfside clinic, or $1,250 for mobile delivery to your home, hotel, or office across South Florida. Physician-prescribed SubQ maintenance kits are separately priced at approximately $150–$300 per supply cycle depending on dose and duration. All sessions include a pre-treatment physician or clinical review. There are no hidden fees.

SubQ and IM injections are similar to any standard shot — a brief pinch with minimal discomfort. IV infusion is different: as the NAD+ enters your bloodstream, you may notice warmth in the face and chest, a mild fluttering sensation, or a feeling of pressure. These sensations are dose-rate dependent and resolve by slowing the infusion. Most patients find the experience manageable, particularly after the first session when they know what to expect. TrufaMED clinicians adjust your rate in real time.

NAD+ injection therapy and IV infusion are not covered by standard health insurance plans for general wellness or optimization purposes. In certain clinical contexts — such as addiction recovery under medical supervision — partial reimbursement may be possible depending on the plan. TrufaMED accepts self-pay and can provide documentation for HSA/FSA reimbursement in applicable cases. We recommend contacting your insurance directly to clarify your specific plan’s position on IV nutrient therapy.

The core difference is clinical oversight. A physician-supervised NAD+ session includes a health review, labs if indicated, contraindication screening, real-time infusion rate management, and the ability to respond medically if an adverse reaction occurs. Medspa settings often administer NAD+ IV under a blanket medical director protocol with no physician physically present — and may not screen for drug interactions or contraindications. TrufaMED operates as a Joint Commission-accredited medical facility, not a wellness spa. A physician is involved in every session.

With IV infusion, many patients notice increased mental clarity and energy during or immediately after the session. Peak cellular effects — improved sleep, sustained energy, reduced fatigue — are typically felt over the 24–72 hours following infusion. SubQ injections work more gradually: most patients notice cumulative improvement over 1–3 weeks of consistent daily use. Effects vary by individual, baseline NAD+ levels, sleep quality, and lifestyle factors during the therapy period.

Yes. NAD+ IV is not recommended during pregnancy. Patients with active cancer should defer to their oncologist before initiating NAD+ therapy, as elevated NAD+ theoretically supports cell proliferation. Individuals with certain cardiac arrhythmias, hemodynamic instability, or severe kidney or liver dysfunction require individual physician assessment before proceeding. Certain psychiatric medications (particularly MAOIs) may interact. A physician review at TrufaMED addresses all of these before your first session.

Yes — NAD+ IV and HBOT are increasingly used together in longevity and performance protocols. HBOT increases oxygen delivery to mitochondria; NAD+ provides the cofactor those mitochondria need to produce ATP efficiently. The combination is synergistic and safe under physician supervision. NAD+ can also be combined with standard IV hydration or vitamin drips on separate days. Same-session stacking (NAD+ IV plus another IV simultaneously) is evaluated case-by-case. Contact our team to discuss a combined protocol.

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are oral NAD+ precursors — the body converts them into NAD+ after absorption. Their advantages are convenience and cost. Their limitations are gut absorption variability, first-pass metabolism, and the dose ceiling of what can be practically swallowed. IV NAD+ bypasses all of these: it delivers the final molecule directly at 100% bioavailability in a single session dose that would be impossible to achieve orally. Many patients use oral precursors daily and IV infusion monthly as a tiered strategy.

Related, but not identical. Niacin (vitamin B3) and its derivatives — nicotinamide and nicotinic acid — are the dietary precursors from which the body synthesizes NAD+. Taking large doses of niacin can raise NAD+ levels, but with well-known side effects including intense flushing. NAD+ injection therapy delivers the end-molecule directly, bypassing the multi-step biosynthesis pathway and avoiding the side-effect profile of high-dose niacin supplementation. They share metabolic ancestry but are clinically distinct interventions.